Revvity, Inc. has introduced its Living Image™ Synergy AI multimodal analysis software, a transformative tool designed for in vivo imaging researchers. This unified platform integrates AI capabilities to streamline data analysis across various imaging modalities, including optical, microCT, and ultrasound. By reducing data inconsistencies and manual tasks, the software enhances workflow efficiency, increases throughput, and improves reproducibility, thereby accelerating scientific discovery.
Also Read: Meta Launches Hyperscape Capture in Beta to Create Photorealistic VR Replicas of Physical Spaces
Kevin Quick, Vice President of Platforms at Revvity, emphasized the significance of this advancement, stating, “Tracking, monitoring, and visualizing biological processes and disease progression is central to understanding complex biology and evaluating potential therapeutics early in development.” The Living Image Synergy AI software aims to unify disparate analysis tools and integrate AI into existing workflows, enabling earlier insights and more consistent analysis across modalities. The software features intuitive co-registration tools and automated processes that reduce manual tasks and analysis time. Advanced AI algorithms automate image segmentation and region-of-interest (ROI) quantification, traditionally labor-intensive and variable steps in imaging analysis. This helps support high-throughput analysis and allows researchers to more efficiently monitor disease progression and assess therapeutic efficacy with greater accuracy and statistical confidence.
